Fredun Pharmaceuticals Ltd
Ticker: FREDUN
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
1460.50
Market Cap
689.60
Debt/Equity
0.8686
ROE %
14.349
PB
5.6771
Promoter %
48.932
Pledge %
0.000
1Y Rev Growth %
30.706
5Y Rev Growth %
32.131
NP Margin %
4.326
NP Margin 5Y Avg %
3.401
Trading Reference
1M Return %
21.352
6M Return %
115.652
1Y Return %
88.306
% Away 52W High
4.478
% Away 52W Low
130.000
Daily Volume
6707
Investment Verdict
Risky
Score 51/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Momentum
Score 80/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Fredun Pharmaceuticals Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is a potential for upside. However, if it falls below the support, downside risk increases.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
G
Gujarat Apollo Industries Ltd
Gujarat Apollo Industries Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and execution risks.
View details
D
Davangere Sugar Company Ltd
Davangere Sugar Company Ltd presents several risks, particularly in terms of growth consistency and market sentiment, making it a risky investment at this time.
View details
O
Onmobile Global Ltd
Onmobile Global Ltd shows potential but faces challenges in growth consistency and market sentiment. Caution is advised.
View details
T
Transworld Shipping Lines Ltd
Transworld Shipping Lines Ltd presents several risks, particularly in terms of growth consistency and market sentiment, making it a risky investment at this time.
View details
S
Suraj Ltd
Suraj Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
C
Captain Technocast Ltd
Captain Technocast Ltd shows potential but faces significant risks in execution and market sentiment, making it a risky investment at this time.
View details
E
Euro Panel Products Ltd
Euro Panel Products Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
M
Munjal Showa Ltd
Munjal Showa Ltd shows potential for growth but faces challenges in profitability and valuation, making it a cautious investment.
View details
E
Emkay Global Financial Services Ltd
Emkay Global Financial Services Ltd presents several risks, particularly in growth consistency and valuation, making it a risky investment at this time.
View details
R
RBZ Jewellers Ltd
RBZ Jewellers Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
D
Dhampur Bio Organics Ltd
Dhampur Bio Organics Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
V
Veljan Denison Ltd
Veljan Denison Ltd shows decent potential with consistent growth and profitability metrics, but faces challenges in valuation and liquidity.
View details
C
Creative Graphics Solutions India Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Alphalogic Techsys Ltd
Alphalogic Techsys Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
A
Advani Hotels and Resorts (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Hercules Hoists Ltd
Hercules Hoists Ltd shows moderate potential but faces challenges in growth and valuation metrics. It is advisable to monitor closely.
View details
Business Overview
Fredun Pharmaceuticals Ltd is a prominent player in the Indian pharmaceutical sector, dedicated to improving health outcomes through innovative healthcare solutions. Catering to a diverse clientele, including hospitals and pharmacies, Fredun focuses on quality and accessibility in its product offerings. With a strong commitment to research and development, the company is poised to address evolving healthcare needs, making it a trusted partner in the industry.
- Established player in the Indian pharmaceutical market
- Focus on quality and innovation
- Wide range of healthcare products
- Strong commitment to research and development
- Trusted partner for healthcare providers
- Dedicated to improving health outcomes for all
Investment Thesis
Fredun Pharmaceuticals Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for long-term success in the evolving pharmaceutical landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Expansion into digital services offers substantial growth opportunities.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Robust product pipeline supports sustained revenue growth.
- Commitment to quality and innovation positions Fredun favorably in the market.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Strong pipeline of new drugs
- Expansion into international markets
- Strategic partnerships with hospitals
Risks ⚠️
- Regulatory changes impacting approvals
- High competition in pharmaceuticals
- Dependence on key patents
- Market volatility affecting stock price
Peer Perspective
Fredun Pharmaceuticals Ltd trades at a discount to peers like Sun Pharmaceutical and Cipla, primarily due to margin volatility. A sustained improvement in operational efficiency could trigger a rerating, aligning its valuation closer to industry standards.
Future Outlook
Fredun Pharmaceuticals Ltd has strong growth potential driven by innovative product pipelines and expanding market presence, provided the company maintains effective execution and cost control measures to navigate industry challenges.
AI FAQs for Retail Users
- Q: What does Fredun Pharmaceuticals Ltd do?A: Fredun Pharmaceuticals Ltd is involved in manufacturing and marketing pharmaceutical products and formulations.
- Q: Is Fredun Pharmaceuticals Ltd a good investment?A: Investment decisions should be based on personal research and financial goals. Consult a financial advisor.
- Q: What are the risks of investing in Fredun Pharmaceuticals Ltd?A: Risks include market volatility, regulatory changes, and company performance. Always consider your risk tolerance.
- Q: How can I buy shares of Fredun Pharmaceuticals Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Where can I find financial reports for Fredun Pharmaceuticals Ltd?A: Financial reports are available on the company's website and through stock exchange filings.
📊 Stock Investment Checklist (100 Points)
Fredun Pharmaceuticals Ltd • Updated: 2025-09-17 14:11:12
-
10BusinessHighPharmaceutical sector shows potential but faces regulatory challenges.
-
10GrowthHighConsistent revenue growth observed, but profit margins are volatile.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Fredun Pharmaceuticals Ltd shows potential for growth but carries risks that need to be monitored closely.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100